دورية أكاديمية

Delays Starting Postoperative Radiotherapy Among Head and Neck Cancer Patients: A Systematic Review and Meta-analysis.

التفاصيل البيبلوغرافية
العنوان: Delays Starting Postoperative Radiotherapy Among Head and Neck Cancer Patients: A Systematic Review and Meta-analysis.
المؤلفون: Duckett KA; Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USA., Kassir MF; Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USA., Nguyen SA; Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USA., Brennan EA; MUSC Libraries, Medical University of South Carolina, Charleston, South Carolina, USA., Chera BS; Department of Radiation Oncology, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA., Sterba KR; Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA., Hughes Halbert C; Department of Population and Public Health Sciences, University of Southern California, Los Angeles, California, USA., Hill EG; Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA., McCay J; Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USA., Puram SV; Department of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine, St Louis, Missouri, USA.; Department of Genetics, Washington University School of Medicine, St Louis, Missouri, USA., Sandulache VC; Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas, USA.; ENT Section, Operative CareLine, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA., Kahmke R; Department of Head and Neck Surgery and Communication Sciences, Duke University, Durham, North Carolina, USA., Ramadan S; Department of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine, St Louis, Missouri, USA., Nussenbaum B; American Board of Otolaryngology-Head and Neck Surgery, Houston, Texas, USA., Alberg AJ; Department of Epidemiology and Biostatistics, University of South Carolina Arnold School of Public Health, Columbia, South Carolina, USA., Graboyes EM; Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.; Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
المصدر: Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery [Otolaryngol Head Neck Surg] 2024 Feb; Vol. 170 (2), pp. 320-334. Date of Electronic Publication: 2023 Sep 20.
نوع المنشور: Meta-Analysis; Systematic Review; Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 8508176 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6817 (Electronic) Linking ISSN: 01945998 NLM ISO Abbreviation: Otolaryngol Head Neck Surg Subsets: MEDLINE
أسماء مطبوعة: Publication: 2023- : [Oxford] : Wiley
Original Publication: [Rochester, Minn.] : The Academy, [c1981-
مواضيع طبية MeSH: Head and Neck Neoplasms*/radiotherapy , Head and Neck Neoplasms*/surgery, Humans ; United States ; Squamous Cell Carcinoma of Head and Neck ; Radiotherapy, Adjuvant
مستخلص: Objective: Initiating postoperative radiotherapy (PORT) within 6 weeks (42 days) of surgery is the first and only Commission on Cancer (CoC) approved quality metric for head and neck squamous cell carcinoma (HNSCC). No study has systematically reviewed nor synthesized the literature to establish national benchmarks for delays in starting PORT.
Data Sources: Following Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines, we performed a systematic review of PubMed, Scopus, and CINAHL.
Review Methods: Studies that described time-to-PORT or PORT delays in patients with HNSCC treated in the United States after 2003 were included. Meta-analysis of proportions and continuous measures was performed on nonoverlapping datasets to examine the pooled frequency of PORT delays and time-to-PORT.
Results: Thirty-six studies were included in the systematic review and 14 in the meta-analysis. Most studies utilized single-institution (n = 17; 47.2%) or cancer registry (n = 16; 44.4%) data. Twenty-five studies (69.4%) defined PORT delay as >6 weeks after surgery (the definition utilized by the CoC and National Comprehensive Cancer Network Guidelines), whereas 4 (11.1%) defined PORT delay as a time interval other than >6 weeks, and 7 (19.4%) characterized time-to-PORT without defining delay. Meta-analysis revealed that 48.6% (95% confidence interval [CI], 41.4-55.9) of patients started PORT > 6 weeks after surgery. Median and mean time-to-PORT were 45.8 (95% CI, 42.4-51.4 days) and 47.4 days (95% CI, 43.4-51.4 days), respectively.
Conclusion: Delays in initiating guideline-adherent PORT occur in approximately half of patients with HNSCC. These meta-analytic data can be used to set national benchmarks and assess progress in reducing delays.
(© 2023 American Academy of Otolaryngology-Head and Neck Surgery Foundation.)
References: Control Clin Trials. 1986 Sep;7(3):177-88. (PMID: 3802833)
Phys Med Biol. 2004 Jul 7;49(13):2827-39. (PMID: 15285250)
Oral Oncol. 2020 Sep;108:104819. (PMID: 32485609)
Head Neck. 2023 Aug;45(8):2108-2119. (PMID: 37194205)
Oral Oncol. 2019 Jan;88:39-48. (PMID: 30616795)
Laryngoscope Investig Otolaryngol. 2021 Nov 09;6(6):1358-1366. (PMID: 34938875)
J Natl Compr Canc Netw. 2021 Sep 22;:1-7. (PMID: 34555804)
Laryngoscope. 2015 Apr;125(4):924-33. (PMID: 25367258)
BMJ. 1997 Sep 13;315(7109):629-34. (PMID: 9310563)
JAMA Otolaryngol Head Neck Surg. 2023 Nov 1;149(11):961-969. (PMID: 37422839)
Laryngoscope. 2018 Oct;128(10):2326-2332. (PMID: 29481712)
JAMA Otolaryngol Head Neck Surg. 2017 Nov 1;143(11):1111-1116. (PMID: 28983555)
Otolaryngol Head Neck Surg. 2020 Jun;162(6):888-896. (PMID: 32093532)
World J Otorhinolaryngol Head Neck Surg. 2019 Jan 11;5(3):160-167. (PMID: 31750429)
PLoS Med. 2009 Jul 21;6(7):e1000097. (PMID: 19621072)
Am J Otolaryngol. 2021 Nov-Dec;42(6):103166. (PMID: 34333218)
Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2):399-412. (PMID: 12738315)
JAMA Otolaryngol Head Neck Surg. 2023 Nov 1;149(11):969-970. (PMID: 37422843)
Head Neck. 2022 Apr;44(4):844-850. (PMID: 35020252)
Head Neck. 2018 Jun;40(6):1147-1155. (PMID: 29394465)
Otolaryngol Head Neck Surg. 2023 Oct;169(4):928-937. (PMID: 36939526)
Head Neck. 2019 Jul;41(7):2299-2308. (PMID: 30737961)
J Med Imaging Radiat Oncol. 2022 Sep;66(6):840-846. (PMID: 35726770)
J Oral Maxillofac Surg. 2019 Nov;77(11):2215-2220. (PMID: 31228426)
Head Neck. 2021 Sep;43(9):2672-2684. (PMID: 33998088)
JCO Oncol Pract. 2021 Oct;17(10):e1512-e1523. (PMID: 33689399)
Cancer Epidemiol. 2016 Dec;45:18-25. (PMID: 27664388)
Laryngoscope. 2020 Nov;130(11):E598-E604. (PMID: 31837165)
Head Neck. 2019 Nov;41(11):3858-3868. (PMID: 31411356)
Laryngoscope. 2020 Feb;130(2):413-417. (PMID: 31021426)
Head Neck. 2020 Oct;42(10):2948-2957. (PMID: 33174308)
Med Sci Monit. 2018 Jun 26;24:4386-4394. (PMID: 29941861)
JAMA Otolaryngol Head Neck Surg. 2019 Feb 1;145(2):166-177. (PMID: 30383146)
JAMA Otolaryngol Head Neck Surg. 2018 Dec 1;144(12):1105-1114. (PMID: 30347012)
Otolaryngol Head Neck Surg. 2018 Jul;159(1):158-165. (PMID: 29631478)
Otolaryngol Head Neck Surg. 2018 Jun;158(6):1051-1056. (PMID: 29313448)
Cancer. 2010 Jul 15;116(14):3505-12. (PMID: 20564123)
Ann Otol Rhinol Laryngol. 2014 Nov;123(11):791-7. (PMID: 24847162)
Head Neck. 2019 Feb;41(2):315-321. (PMID: 30548892)
Cancer. 2017 Jul 15;123(14):2651-2660. (PMID: 28241092)
Cancer. 2020 Nov 15;126(22):4905-4916. (PMID: 32931057)
N Engl J Med. 2004 May 6;350(19):1937-44. (PMID: 15128893)
JAMA Otolaryngol Head Neck Surg. 2020 May 1;146(5):455-464. (PMID: 32239201)
J Surg Oncol. 1990 Apr;43(4):203-8. (PMID: 2325418)
Otolaryngol Head Neck Surg. 2018 Dec;159(6):987-997. (PMID: 30060700)
J Clin Epidemiol. 2001 Oct;54(10):1046-55. (PMID: 11576817)
Laryngoscope. 2018 Dec;128(12):2751-2758. (PMID: 29756382)
Head Neck. 2019 Jul;41(7):2182-2189. (PMID: 30723965)
Cancer. 2017 Dec 15;123(24):4841-4850. (PMID: 28841234)
Cancer. 2017 Nov 15;123(22):4372-4381. (PMID: 28727137)
J Clin Oncol. 2003 Feb 1;21(3):555-63. (PMID: 12560449)
Laryngoscope Investig Otolaryngol. 2018 Aug 09;3(4):275-282. (PMID: 30186958)
JCO Oncol Pract. 2020 Dec;16(12):e1417-e1432. (PMID: 32853120)
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e197-206. (PMID: 21596483)
Laryngoscope. 2020 Nov;130(11):E587-E592. (PMID: 31756005)
Cancer. 2018 Aug 1;124(15):3154-3162. (PMID: 29742280)
JAMA Otolaryngol Head Neck Surg. 2022 Aug 1;148(8):715-716. (PMID: 35708673)
JAMA Otolaryngol Head Neck Surg. 2023 Jun 1;149(6):477-484. (PMID: 37079327)
Int J Radiat Oncol Biol Phys. 2001 Nov 1;51(3):571-8. (PMID: 11597795)
Head Neck. 2019 Jun;41(6):1756-1769. (PMID: 30615247)
Head Neck. 2021 Nov;43(11):3530-3539. (PMID: 34492135)
JAMA Otolaryngol Head Neck Surg. 2018 Apr 01;144(4):349-359. (PMID: 29522072)
N Engl J Med. 2004 May 6;350(19):1945-52. (PMID: 15128894)
Oral Oncol. 2022 Mar;126:105781. (PMID: 35183910)
Am J Clin Oncol. 2011 Jun;34(3):276-80. (PMID: 20622647)
J Natl Compr Canc Netw. 2022 Mar;20(3):224-234. (PMID: 35276673)
معلومات مُعتمدة: K08 CA237858 United States CA NCI NIH HHS; P30 CA138313 United States CA NCI NIH HHS; R01 CA282165 United States CA NCI NIH HHS
فهرسة مساهمة: Keywords: Commission on Cancer; National Comprehensive Cancer Network; adjuvant therapy; head and neck cancer; quality; radiotherapy
تواريخ الأحداث: Date Created: 20230921 Date Completed: 20240119 Latest Revision: 20240206
رمز التحديث: 20240206
مُعرف محوري في PubMed: PMC10840985
DOI: 10.1002/ohn.538
PMID: 37731255
قاعدة البيانات: MEDLINE